Akers Biosciences, Inc is a medical instruments & supplies business based in the US. Akers Biosciences shares (AKER) are listed on the NASDAQ and all prices are listed in US Dollars. Akers Biosciences employs 4 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Akers Biosciences
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AKER – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Akers Biosciences stock price (NASDAQ: AKER)Use our graph to track the performance of AKER stocks over time.
Akers Biosciences shares at a glance
|Latest market close||$648.00|
|52-week range||$1.65 - $6.97|
|50-day moving average||$6.49|
|200-day moving average||$5.23|
|Wall St. target price||$4.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.72|
Buy Akers Biosciences shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Akers Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Akers Biosciences price performance over time
|1 week (2021-07-23)||N/A|
|1 month (2021-06-29)||N/A|
|3 months (2021-05-03)||4.52%|
|6 months (2021-01-30)||N/A|
|1 year (2020-07-30)||N/A|
|2 years (2019-07-30)||N/A|
|3 years (2018-07-30)||N/A|
|5 years (2016-07-30)||N/A|
Akers Biosciences financials
|Revenue TTM||$1.6 million|
|Gross profit TTM||$478,747|
|Return on assets TTM||-32.18%|
|Return on equity TTM||-55.32%|
|Market capitalisation||$20.6 million|
TTM: trailing 12 months
Shorting Akers Biosciences shares
There are currently 1.6 million Akers Biosciences shares held short by investors – that's known as Akers Biosciences's "short interest". This figure is 16.5% down from 1.9 million last month.
There are a few different ways that this level of interest in shorting Akers Biosciences shares can be evaluated.
Akers Biosciences's "short interest ratio" (SIR)
Akers Biosciences's "short interest ratio" (SIR) is the quantity of Akers Biosciences shares currently shorted divided by the average quantity of Akers Biosciences shares traded daily (recently around 321659.8019802). Akers Biosciences's SIR currently stands at 5.05. In other words for every 100,000 Akers Biosciences shares traded daily on the market, roughly 5050 shares are currently held short.
However Akers Biosciences's short interest can also be evaluated against the total number of Akers Biosciences shares, or, against the total number of tradable Akers Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Akers Biosciences's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Akers Biosciences shares in existence, roughly 100 shares are currently held short) or 0.1041% of the tradable shares (for every 100,000 tradable Akers Biosciences shares, roughly 104 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Akers Biosciences.
Find out more about how you can short Akers Biosciences stock.
Akers Biosciences share dividends
We're not expecting Akers Biosciences to pay a dividend over the next 12 months.
Have Akers Biosciences's shares ever split?
Akers Biosciences's shares were split on a 1:24 basis on 24 November 2019. So if you had owned 24 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Akers Biosciences shares – just the quantity. However, indirectly, the new 2300% higher share price could have impacted the market appetite for Akers Biosciences shares which in turn could have impacted Akers Biosciences's share price.
Akers Biosciences share price volatility
Over the last 12 months, Akers Biosciences's shares have ranged in value from as little as $1.65 up to $6.97. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akers Biosciences's is 0.3354. This would suggest that Akers Biosciences's shares are less volatile than average (for this exchange).
Akers Biosciences overview
Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. It has a collaboration agreement with Premas Biotech PVT Ltd. The company was incorporated in 1989 and is headquartered in New York, New York. .
Akers Biosciences in the news
Frequently asked questionsWhat percentage of Akers Biosciences is owned by insiders or institutions?
Currently 12.511% of Akers Biosciences shares are held by insiders and 13.406% by institutions. How many people work for Akers Biosciences?
Latest data suggests 4 work at Akers Biosciences. When does the fiscal year end for Akers Biosciences?
Akers Biosciences's fiscal year ends in December. Where is Akers Biosciences based?
Akers Biosciences's address is: 1185 Avenue of the Americas, New York, NY, United States, 10036 What is Akers Biosciences's ISIN number?
Akers Biosciences's international securities identification number is: US00973E4098 What is Akers Biosciences's CUSIP number?
Akers Biosciences's Committee on Uniform Securities Identification Procedures number is: 00973E102
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert